Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 29 articles PubMed · modèle : gemma4:31b
Résumé
Sweet basil (Ocimum basilicum) is an aromatic medicinal plant of the Lamiaceae family used for its diverse pharmacological properties, including antioxidant, antimicrobial, and anti-inflammatory effects [PMID:35741897, PMID:38140476].
Contexte
Ocimum basilicum L., commonly known as sweet basil, is a widely consumed aromatic herb and medicinal plant used globally as a spice and in traditional medicine [PMID:29865879, PMID:35741897, PMID:37446986].
Usages traditionnels
Traditional medicine uses include treatment of gastrointestinal disorders, inflammation, immune system issues, pyrexia, cancer [PMID:35741897], cardiovascular diseases, and obesity [PMID:38328459]. It is also used to treat various types of fever [PMID:36771120] and respiratory disorders [PMID:35046828]. In Persian traditional medicine, it has been used both as a galactogogue and to decrease breastmilk oversupply [PMID:30000886].
Composés actifs
The plant contains phytochemicals including linalool, 1,8-cineole (eucalyptol), estragole, eugenol, methylchavicol, and methylcinnamate [PMID:30000886, PMID:38140476]. Other bioactive constituents include alkaloids, phenolics, flavonoids, tannins, saponins, cardiac glycosides, steroids, and glycosides [PMID:38257301].
Mécanisme d'action
Basil may act as a radical scavenger to alleviate oxidative stress [PMID:38433659]. Computational studies suggest O. basilicum miRNAs may modulate human target genes associated with PI3K-AKT and MAPK signaling pathways [PMID:29775783]. It may also improve inflammatory mediators such as IL-10, IL-4, TNF-α, IFN-γ, and nitric oxide (NO) [PMID:37275758].
Preuves cliniques
Preuve DBacterial Infections
Ethanol extracts of leaves inhibited Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli in vitro [PMID:36800828].
Preuve DDiabetes-induced Renal Affection
In albino rats, O. basilicum significantly decreased blood glucose levels and increased total anti-oxidant capacity (TAC) compared to untreated diabetic rats [PMID:32082085].
Preuve DNeurotoxicity (AlCl3-induced)
Leaf and seed extracts alleviated neuronal dysfunction and oxidative biomarkers in a Drosophila melanogaster model [PMID:38433659].
Preuve DDengue Virus (DENV)
The lipophilic fraction of the stem showed significant reduction in DENV titre in vitro [PMID:36771120].
Preuve DPancreatic Cancer
Extracellular vesicles purified from basil leaves demonstrated apoptosis-inducing abilities in pancreatic cancer cells [PMID:38939903].
Sécurité et effets indésirables
Basil is generally recognized as safe (GRAS) as a food by the U.S. FDA [PMID:30000886]. However, concerns have been raised regarding alkenylbenzenes (such as estragole), which may be procarcinogens or promutagens [PMID:30000886, PMID:29865879].
Grossesse et allaitement
Basil appears safe during breastfeeding in food amounts, but medicinal doses are recommended against during lactation due to estragole content and lack of safety data [PMID:30000886].
Synthèse des preuves
The current evidence is primarily based on in vitro studies, animal models (rats, Drosophila), and literature reviews. There are no scientifically valid clinical trials supporting its use as a galactogogue [PMID:30000886].
2.PMID: 38140476 (2023) — Sweet Basil (Ocimum basilicum L.)-A Review of Its Botany, Phytochemistry, Pharmacological Activities, and Biotechnological Development. · Plants (Basel, Switzerland)
3.PMID: 35741897 (2022) — Differential Nutrition-Health Properties of Ocimum basilicum Leaf and Stem Extracts. · Foods (Basel, Switzerland)
4.PMID: 38433659 (2024) — Sweet basil (Ocimum basilicum) leaf and seed extracts alleviate neuronal dysfunction in aluminum chloride-induced neurotoxicity in Drosophila melanogaster Meigen model. · Drug and chemical toxicology
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
— The potential effects of Ocimum basilicum on health: a review of pharmacological and toxicological studies.
· Expert opinion on drug metabolism & toxicology
6.PMID: 38257301 (2024) — Antimicrobial and Other Pharmacological Properties of Ocimum basilicum, Lamiaceae. · Molecules (Basel, Switzerland)
7.PMID: 38188439 (2023) — The complete chloroplast genome of Ocimum basilicum L. var. basilicum (Lamiaceae) and its phylogenetic analysis. · Mitochondrial DNA. Part B, Resources
9.PMID: 37275758 (2023) — Anti-inflammatory, immunomodulatory and anti-oxidant effects of Ocimum basilicum L. and its main constituents: A review. · Iranian journal of basic medical sciences
10.PMID: 38813679 (2025) — Bio-active compounds and major biomedical properties of basil (Ocimum basilicum, lamiaceae). · Natural product research
11.PMID: 36800828 (2022) — Assessment of The Antibacterial Susceptibility of Ocimum basilicum. · Cellular and molecular biology (Noisy-le-Grand, France)
12.PMID: 37446986 (2023) — Basil (Ocimum basilicum) Landraces Can Be Used in a Water-Limited Environment. · Plants (Basel, Switzerland)
13.PMID: 35046828 (2021) — The Effect of Ocimum basilicum L. and Its Main Ingredients on Respiratory Disorders: An Experimental, Preclinical, and Clinical Review. · Frontiers in pharmacology
14.PMID: 38328459 (2024) — Chloroplast genome of Ocimum basilicum var. purpurascens Bentham 1830 (Lamiaceae). · Mitochondrial DNA. Part B, Resources
15.PMID: 38939903 (2024) — Anti-cancer bioactivity of sweet basil leaf derived extracellular vesicles on pancreatic cancer cells. · Journal of extracellular biology
16.PMID: 32082085 (2019) — Renoprotective Effect of Ocimum Basilicum (Basil) Against Diabetes-induced Renal Affection in Albino Rats. · Materia socio-medica
17.PMID: 36771120 (2023) — Anti-Dengue Activity of Lipophilic Fraction of Ocimum basilicum L. Stem. · Molecules (Basel, Switzerland)
18.PMID: 34202798 (2021) — Basil Seeds as a Novel Food, Source of Nutrients and Functional Ingredients with Beneficial Properties: A Review. · Foods (Basel, Switzerland)